Podcast Episodes

Reformulating psychedelics for neurodegenerative diseases

There is a clear demand for novel, neurological treatments. While it’s widely known psychedelics hold enormous therapeutic potential, there are a hos…

2 years, 7 months ago

How AI immune system mapping can boost drug discovery

Immunai is mapping the immune system at unprecedented scale and granularity. The map, paired with machine learning, looks at how the immune system wi…

2 years, 7 months ago

Is Tome writing the final chapter in genomic medicine?

Tome Biosciences recently exited stealth mode with almost a quarter of a billion dollars in funding. The company has developed a new approach to gene…

2 years, 7 months ago

Transforming treatments for epilepsy

After decades of lagging nearly many other disease areas, neurology is finally seeing signs of significant innovation. 

One of the biggest reasons it’…

2 years, 7 months ago

How does AI assist drug discovery?

Artificial intelligence (AI) is certainly in the news constantly; however, it’s been used in drug discovery for some time.

A new collaboration between…

2 years, 8 months ago

Biosimilars and what’s new in cell and gene therapies

This week on the podcast, we have a conversation with Fran Gregory, vice president of Emerging Therapies at Cardinal Health.

The discussion covers th…

2 years, 8 months ago

BioSenic developing severe knee osteoarthritis treatment

BioSenic, a Belgian clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, will share data on its late…

2 years, 8 months ago

Boosting fertility by changing the vaginal microbiome

Freya Biosciences is a clinical-stage biotech company dedicated to reimagining women's health and redefining fertility for those previously deprived …

2 years, 8 months ago

Epic Bio - gene editing without cutting DNA

Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA.

The company’s proprietary Gene Expression Modulation S…

2 years, 8 months ago

Could natural killer cells transform Alzheimer’s treatment?

A US company, with its origins in South Korea, is using natural killer (NK) cells to treat Alzheimer’s disease, with remarkable results.

This week, we…

2 years, 9 months ago